Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
23.09
-1.58 (-6.40%)
At close: Mar 6, 2026, 4:00 PM EST
23.50
+0.41 (1.78%)
After-hours: Mar 6, 2026, 7:01 PM EST
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $319.9 million as of March 6, 2026. Its market cap has increased by 102.13% in one year.
Market Cap
319.90M
Enterprise Value
317.62M
1-Year Change
102.13%
Ranking
Category
Stock Price
$23.09
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $319.90M, an increase of 365.73%. That is a compound annual growth rate of 32.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 319.90M | 9.90% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 361.97M |
| Candel Therapeutics | 355.25M |
| Climb Bio | 352.83M |
| Neurogene | 342.79M |
| Adlai Nortye | 340.96M |
| Foghorn Therapeutics | 329.52M |
| Opus Genetics | 328.96M |
| Avalo Therapeutics | 325.45M |